You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular Complete Remissions

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Leukemia Trial in France (Additional biological samples)

Active, not recruiting
  • Chronic Leukemia
  • Additional biological samples
  • Besançon, France
  • +3 more
May 31, 2022

Strategy for Resected NSCLC Longitudinal Undetectable MRD

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Molecular residual disease test
  • (no location specified)
Jul 9, 2022

Metastatic Colorectal Cancer Trial (Niraparib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Jun 7, 2022

CharactHer. ICORG 12-09, V3

Terminated
  • HER2-positive Breast Cancer
  • TNM Stage II-IV Breast Cancer
    • Dublin, Ireland
    • +1 more
    Jan 14, 2022

    CR With Sunitinib Treatment In mRCC Patients

    Completed
    • Complete Remission in Renal Cell Carcinoma
    • Marseille, Cedex 5, France
    • +13 more
    Feb 14, 2022

    Chronic Phase Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib)

    Completed
    Has Results
    • Chronic Phase Chronic Myeloid Leukemia
    • Duarte, California
    • +27 more
    Dec 7, 2021

    Leukemia, Chronic Myeloid Trial in Ann Arbor, Winston-Salem (Nilotinib, Ruxolitinib)

    Withdrawn
    • Leukemia, Chronic Myeloid
    • Ann Arbor, Michigan
    • +1 more
    Feb 11, 2021

    Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

    Recruiting
    • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
    • Olverembatinib plus venetoclax and dexamethasone
    • Xi'an, Shannxi, China
      Department of Hematology, Xijing Hospital, Fourth Military Medic
    Oct 9, 2023

    Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)

    Active, not recruiting
    • Lymphoblastic Leukemia, Acute, Adult
    • +2 more
    • Brno, Czechia
    • +4 more
    Aug 3, 2022

    Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • +2 more
    • Ponatinib 15 MG Oral Tablet
    • Brno, Czechia
    • +6 more
    Nov 30, 2022

    Leukemia, Myeloid, Chronic-Phase Trial in Bordeaux (Imatinib Mesylate 600 MG Oral Tablet, Imatinib Mesylate 400 MG Oral Tablet,

    Terminated
    Has Results
    • Leukemia, Myeloid, Chronic-Phase
    • Imatinib Mesylate 600 MG Oral Tablet
    • +2 more
    • Bordeaux, Aquitaine, France
      Institut Bergonié
    Dec 30, 2020

    Nephrotic Syndrome, Proteinuria, Autoimmune Disease Trial run by the NIDDK (Rituximab Infusion, Oral Cyclosporine)

    Recruiting
    • Nephrotic Syndrome
    • +4 more
    • Rituximab Infusion
    • Oral Cyclosporine
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    ALL, Recurrent, Adult Trial in Frankfurt (Main), Kiel (Blinatumomab, Venetoclax)

    Recruiting
    • ALL, Recurrent, Adult
    • Frankfurt (Main), Hessen, Germany
    • +1 more
    Jan 6, 2022

    Leukemia, Myelocytic, Acute Trial in Czechia, Germany (study part 1 - dose daunorubicin, induction cycles)

    Recruiting
    • Leukemia, Myelocytic, Acute
    • study part 1 - dose daunorubicin
    • induction cycles
    • Brno, Czechia
    • +39 more
    Sep 6, 2021

    Breast Cancer Trial in Spain (Irradiation)

    Terminated
    • Breast Cancer
    • Irradiation
    • Barakaldo, Bilbao, Spain
    • +19 more
    Oct 25, 2021

    Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

    Recruiting
    • Follicular Lymphoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 25, 2022

    Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

    Completed
    Has Results
    • Mantle Cell Lymphoma
    • Lymphoma, Mantle Cell
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 4, 2023

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (BP1002; Liposomal Bcl-2 Antisense

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide
    • Decitabine (in combination with BP1002)
    • (no location specified)
    Mar 8, 2022

    Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Jena, Germany
      Universitätsklinikum Jena
    Jan 17, 2023

    Discontinuing Tyrosin Kinase Inhibitors in Chronic Myeloid

    Completed
    • Hematologic Diseases
    • Chronic Myeloid Leukemia
    • Budget impact
    • Bordeaux, France
      CHU Bordeaux
    Apr 27, 2020

    Vital Pulp Therapy Trial in Mansoura (Pulp therapy, Cytokines level in pulpal blood.)

    Completed
    • Vital Pulp Therapy
    • Pulp therapy
    • Cytokines level in pulpal blood.
    • Mansoura, Dakahliya, Egypt
      Mansoura University
    Jul 18, 2022

    Complete Molecular Remission After Stopping Imatinib Chronic

    Completed
    • Chronic Myeloid Leukemia
    • Interruption of the treatment by Imatinib
    • Angers, France
    • +18 more
    Jun 18, 2020

    B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)

    Recruiting
    • B Acute Lymphoblastic Leukemia
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Nov 1, 2022

    Breast Cancer, Radiotherapy Trial in Bologna (SBRT anticipated boost)

    Recruiting
    • Breast Cancer
    • Radiotherapy
    • SBRT anticipated boost
    • Bologna, Italy
      IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Jan 9, 2023